Table 1.

Comparison between anthropometric and laboratory tests at baseline and after 4 years of treatment with sitagliptin and vitamin D3 in two young women with type 1 diabetes mellitus.

Use of sitagliptin and vitamin D3 (at baseline and after 4 years of treatment)	FBG (mg/dL)	Weight (kg)	BMI (kg/m2)	Calcium (mg/dL)	Vitamin D (ng/mL)	Insulin dose (IU/kg)	Anti-TPO (IU/mL)	Anti-TG (IU/mL)
Patient #1
Baseline	320	62	21.7	10	22.1	0.79	452	70.7
4 years	82	75	26.2	9	43.7	0	24.65	29.5
Patient #2
Baseline	303	62.5	19.5	9.6	55.8	0.55	36.2	197
4 years	85	63	19.66	8.9	62.5	0.19	13.5	82.6

Reference values: 25(OH) vitamin D (ELISA): 30–100 ng/mL, anti-TPO (ELISA): <35 IU/mL, anti-TG (ELISA): <40 IU/mL, calcium: 8.5–10.5 mg/dL (colorimetric, Arsenazo III). All tests were performed in the same laboratory (Carlos Chagas, Cuiabá, Brazil).

anti-TG, antithyroglobulin antibody; anti-TPO, antithyroperoxidase antibody; BMI, body mass index; FBG, fasting blood glucose.